Immatics to receive upfront payment of US $ 150 million and additional milestone payments of up to US $ 770 million plus tiered double-digit royalties on net product sales
The company is focused on the development of novel treatments for RNA viruses
Whipple procedure is a very complex operation, mainly performed to remove pancreatic cancer
The license agreement grants Dr. Reddy's the exclusive rights to commercialize the proposed biosimilar in select countries in Latin America and Southeast Asia
Approximately five kg tumor was removed in the eight-hour long complicated surgery
Investment in single-use endoscopes, digital solutions, and endoluminal therapies expected
SPARC will pay Biomodifying a percentage of payments received for sublicenses of the licensed IP
This further adds to Biocon’s portfolio of vertically integrated complex drug products
_256_384.jpg)
Destiny-Breast11 will evaluate Enhertu as a monotherapy or Enhertu followed by paclitaxel, trastuzumab and pertuzumab
The company has has 10 existing labs in India
Subscribe To Our Newsletter & Stay Updated
